Amy O'Connell

Dr. Amy O’Connell is a physician scientist who has clinical training in pediatrics, allergy/immunology, and neonatology. She attended medical and graduate school at what is now Jefferson University in Philadelphia and did her pediatrics residency at the University of Vermont. She has been in Boston since 2012 when she started her fellowship training at Boston Children’s Hospital, completing fellowships in allergy/immunology in 2014 and neonatal perinatal medicine in 2017. Her research focuses on developmental biology and neonatal immunity. The biggest focuses of the laboratory are intestinal stem cell biology and immune maturation in former preterm infants.

Education

• M.D. Jefferson Medical College of Thomas Jefferson University (2002 — 2009)
• PhD Thomas Jefferson University (2002 — 2009)
• B.S. Merrimack College (1998 — 2002)

Publications

Insights into the Role of Commensal-Specific T Cells in Intestinal Inflammation. J Inflamm Res. 2022; 15:1873-1887. ViewInsights into the Role of Commensal-Specific T Cells in Intestinal Inflammation.

Identifying Neonates at Lowest Risk for Sepsis. Pediatrics. 2022 02 01; 149(2). ViewIdentifying Neonates at Lowest Risk for Sepsis.

Inborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis. Front Immunol. 2021; 12:758373. ViewInborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis.

Novel variants in the stem cell niche factor WNT2B define the disease phenotype as a congenital enteropathy with ocular dysgenesis. Eur J Hum Genet. 2021 06; 29(6):998-1007. ViewNovel variants in the stem cell niche factor WNT2B define the disease phenotype as a congenital enteropathy with ocular dysgenesis.

Gene and Stem Cell Therapies for Fetal Care: A Review. JAMA Pediatr. 2020 10 01; 174(10):985-991.